A peripheral nerve block is a targeted interventional procedure that delivers local anesthetic, corticosteroid, or both, adjacent to a specific named peripheral nerve outside the neuraxis (spinal cord and nerve roots) to diagnose or treat neuropathic and nociceptive pain arising from that nerve's distribution. Unlike epidural injections or plexus-level blocks, which target large nerve bundles or the central neuraxis, peripheral nerve blocks are distinguished by their anatomic specificity — each block is designed to silence a single named nerve or a small set of anatomically related nerves at a discrete location along its course. This precision allows for maximum therapeutic benefit with minimal systemic effects and a very favorable safety profile.
The clinical applications of peripheral nerve blocks are remarkably diverse, reflecting the wide variety of peripheral nerves that can become symptomatic. At Interventional Pain Consultants, we commonly perform blocks of the lateral femoral cutaneous nerve (for meralgia paresthetica — a painful entrapment neuropathy of the lateral thigh), the suprascapular nerve (for chronic shoulder pain from osteoarthritis, rotator cuff pathology, or adhesive capsulitis), the ilioinguinal and iliohypogastric nerves (for groin pain following inguinal hernia repair or abdominal surgery), the genitofemoral nerve (for chronic groin and genital pain), the saphenous nerve (for medial knee and lower leg pain), the sural nerve (for lateral foot and ankle pain), and the superficial peroneal nerve (for dorsal foot pain).
Each peripheral nerve block serves a dual function: diagnostically, it identifies the specific nerve responsible for the patient's pain — information that is invaluable for surgical planning, targeted physical therapy, and patient education — and therapeutically, it provides a window of profound pain relief during which the anti-inflammatory and membrane-stabilizing effects of the injectate can interrupt the cycle of chronic pain and facilitate progress in functional rehabilitation. At Interventional Pain Consultants, peripheral nerve blocks are performed under ultrasound guidance by board-certified, fellowship-trained interventional pain specialists, ensuring that the injectate is deposited precisely around the target nerve while critical adjacent structures — vessels, tendons, and motor nerves — are carefully avoided.
The technical approach to peripheral nerve block varies according to the specific nerve being targeted, its anatomic location, its depth, and its relationship to adjacent structures. In every case, the procedure begins with a focused ultrasound examination to identify the target nerve, confirm its position using cross-sectional and longitudinal imaging, and identify the optimal needle trajectory that will reach the nerve while avoiding critical adjacent structures (arteries, veins, motor nerves, tendons, and pleura where relevant). The nerve is typically identified as a hyperechoic (bright), honeycomb-shaped structure on short-axis ultrasound view.
After sterile preparation of the skin and administration of subcutaneous local anesthesia, a 25- or 27-gauge needle is advanced under real-time ultrasound visualization using an in-plane or out-of-plane technique, depending on the anatomic target and operator preference. The needle tip is positioned within the perineural sheath — the connective tissue layer that surrounds the nerve — but not within the nerve itself (intraneural injection is avoided to prevent nerve injury). Once satisfactory needle-tip position is confirmed on ultrasound, negative aspiration is performed, and 1-5 mL of injectate — typically 0.25-0.5% bupivacaine combined with 20-40 mg of methylprednisolone acetate — is deposited around the nerve. The spread of injectate around the nerve (the "halo" sign) is visualized in real time on ultrasound, confirming successful perineural delivery.
The procedure is performed on an outpatient basis and typically requires 10-20 minutes of procedure time, depending on the complexity of the target nerve. The patient is positioned to optimize access to the target area — supine for lateral femoral cutaneous or saphenous blocks, prone or lateral for suprascapular blocks, or supine with the leg externally rotated for obturator blocks. Patients are awake during the procedure and may feel mild discomfort from the initial local anesthetic infiltration, but the subsequent needle advancement under ultrasound guidance is typically associated with only pressure sensation.
Following the injection, patients experience immediate numbness and often a sensation of warmth in the sensory distribution of the blocked nerve — a reassuring sign of technical success. The degree of motor blockade depends on whether the target nerve is a pure sensory nerve (such as the lateral femoral cutaneous nerve) or a mixed sensory-motor nerve (such as the suprascapular or saphenous nerve). Patients are counseled about the expected duration and extent of any motor weakness and are provided with appropriate safety precautions (use of crutches, avoidance of stairs, etc.) when necessary.
The local anesthetic component of the block provides immediate relief lasting 4-12 hours. Patients are advised to rest the affected area during this period and to avoid activities that could result in injury to the anesthetized region (such as walking without assistance if a lower extremity block was performed). As the local anesthetic wears off, patients may experience a gradual return of sensation — often beginning as a tingling or pins-and-needles sensation — followed by a return of their baseline pain. The corticosteroid component begins to take effect within 2-7 days and provides the longer-term therapeutic benefit.
Patients can typically resume normal activities within 24-48 hours, with the exception of heavy lifting, vigorous exercise, or activities that place direct pressure on the injection site. A series of 2-3 blocks spaced 4-6 weeks apart may be recommended for patients with chronic entrapment neuropathies or persistent post-surgical pain. For patients who derive excellent but temporary relief, peripheral nerve stimulation — an implantable neuromodulation technology — may be discussed as a durable, long-term solution.
Patient selection for peripheral nerve block begins with a meticulous history and physical examination to localize the source of pain to a specific peripheral nerve distribution. Electrodiagnostic studies (nerve conduction studies and electromyography) may be helpful in confirming the diagnosis of entrapment neuropathy, particularly when the history and physical examination are equivocal, when there is concern for more widespread peripheral neuropathy, or when surgical decompression is being considered. Imaging studies — including ultrasound and MRI — can identify structural causes of nerve entrapment, such as fibrous bands, tumors, cysts, or postsurgical scar tissue.
Contraindications include active infection at the injection site, coagulopathy or anticoagulant therapy that cannot be safely interrupted, known allergy to local anesthetics or corticosteroids, and preexisting complete nerve transection (in which a nerve block is diagnostically unhelpful and therapeutically futile). At Interventional Pain Consultants, we take a comprehensive approach to peripheral nerve pain management, combining peripheral nerve blocks with physical therapy, desensitization techniques, ergonomic optimization, medication management, neuromodulation, and — when indicated — surgical consultation for definitive nerve decompression.
Reducing Pain. Improving Function. Enhancing Quality of Life.
We specialize in advanced pain management solutions, offering minimally invasive treatments to help patients live pain-free and improve their quality of life.